CS163723B2 - - Google Patents

Info

Publication number
CS163723B2
CS163723B2 CS4207A CS420768A CS163723B2 CS 163723 B2 CS163723 B2 CS 163723B2 CS 4207 A CS4207 A CS 4207A CS 420768 A CS420768 A CS 420768A CS 163723 B2 CS163723 B2 CS 163723B2
Authority
CS
Czechoslovakia
Application number
CS4207A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS163723B2 publication Critical patent/CS163723B2/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS4207A 1967-06-09 1968-06-06 CS163723B2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967SC040852 DE1643027B2 (de) 1967-06-09 1967-06-09 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe

Publications (1)

Publication Number Publication Date
CS163723B2 true CS163723B2 (xx) 1975-11-07

Family

ID=7435899

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4207A CS163723B2 (xx) 1967-06-09 1968-06-06

Country Status (17)

Country Link
US (1) US3789087A (xx)
AT (1) AT280499B (xx)
BE (1) BE716258A (xx)
BR (1) BR6899582D0 (xx)
CH (1) CH560230A5 (xx)
CS (1) CS163723B2 (xx)
DE (1) DE1643027B2 (xx)
DK (2) DK124610B (xx)
ES (1) ES354795A1 (xx)
FI (1) FI45176C (xx)
FR (2) FR1588812A (xx)
GB (1) GB1240339A (xx)
NL (1) NL161768C (xx)
NO (1) NO129522B (xx)
PL (1) PL73566B1 (xx)
SE (1) SE341396B (xx)
YU (1) YU33977B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792152B1 (en) 1994-11-22 2004-04-14 Balance Pharmaceuticals, Inc. Methods of contraception

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838773A (en) * 1955-07-20 1960-06-22 Farmaceutici Italia 4-substituted steroid compounds and preparation thereof
US3452058A (en) * 1958-11-13 1969-06-24 Syntex Corp 6-substituted-6-dehydro androstanes and pregnanes
GB1050218A (xx) * 1964-10-13
DE1593516C3 (de) * 1966-08-25 1975-05-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4-Halogen-1,2 alpha; 6,7 betabismethylen-delta hoch 4-3-ketosteroide, Verfahren zu ihrer Herstellung sowie diese Steroide enthaltende Mittel
US3707537A (en) * 1969-01-08 1972-12-26 Hoffmann La Roche 4-chloro-4,6-diene-6-halo or lower alkyl steroids

Also Published As

Publication number Publication date
NL161768B (nl) 1979-10-15
FR1588812A (xx) 1970-03-16
AT280499B (de) 1970-04-10
BR6899582D0 (pt) 1973-05-10
CH560230A5 (xx) 1975-03-27
YU127868A (en) 1978-02-28
DE1643027B2 (de) 1977-12-08
NL6808107A (xx) 1968-12-10
DE1643027C3 (xx) 1978-08-17
FR8342M (xx) 1970-12-21
BE716258A (xx) 1968-12-09
NL161768C (nl) 1980-03-17
DE1643027A1 (de) 1971-04-15
ES354795A1 (es) 1969-11-01
YU33977B (en) 1978-09-08
NO129522B (xx) 1974-04-22
SE341396B (xx) 1971-12-27
US3789087A (en) 1974-01-29
FI45176C (fi) 1972-04-10
DK124610B (da) 1972-11-06
DK128189B (da) 1974-03-18
PL73566B1 (xx) 1974-10-31
GB1240339A (en) 1971-07-21
FI45176B (xx) 1971-12-31

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
AT298283B (xx)
FI45176B (xx)
AU416737B2 (xx)
AU342066A (xx)
AU610966A (xx)
AU1273466A (xx)
BE692493A (xx)
BE514578A (xx)
BE609869A (xx)
BE693070A (xx)
BE692780A (xx)
BE692779A (xx)
BE692778A (xx)
BE692654A (xx)
BE692577A (xx)
BE692553A (xx)
BE692552A (xx)
BE609934A (xx)
BE692409A (xx)
BE692375A (xx)
BE692374A (xx)
BE692332A (xx)
BE692199A (xx)
BE692922A (xx)